Company Filing History:
Years Active: 2003-2005
Title: Darlise O'Connor: Innovator in Medical Treatments
Introduction
Darlise O'Connor is a notable inventor based in Newark, DE (US). He has made significant contributions to the field of medical treatments, particularly in addressing respiratory and intestinal issues. With a total of 2 patents, O'Connor's work has the potential to improve the quality of life for many patients.
Latest Patents
O'Connor's latest patents include a method for treating respiratory distress syndrome and a method for enhancing intestinal function using leptin. The first patent provides a method for treating infants, children, or adults suffering from pulmonary distress caused by low or insufficient production of surfactant. This method is particularly beneficial for premature infants suffering from Respiratory Distress Syndrome. It involves administering a leptin compound to enhance surfactant production in individuals with impaired lung function.
The second patent describes a method for treating patients with inadequate intestinal function. By administering leptin, this method increases intestinal function beyond that of a normal adaptive response. It also enhances amino acid and sugar absorption, which can be crucial for patients with various gastrointestinal conditions, including short bowel syndrome and inflammatory bowel disease.
Career Highlights
Darlise O'Connor is affiliated with The Nemours Foundation, where he continues to work on innovative medical solutions. His research focuses on leveraging leptin's properties to address critical health issues, showcasing his commitment to advancing medical science.
Collaborations
O'Connor collaborates with esteemed colleagues, including Marshall Z Schwartz and Vicky L Funanage, who contribute to his research efforts. Their combined expertise enhances the potential impact of their work in the medical field.
Conclusion
Darlise O'Connor's innovative patents and dedication to medical research highlight his significant role in developing treatments for respiratory and intestinal disorders. His contributions are poised to make a lasting impact on patient care and medical advancements.